← back to search

Martin Cornillet

Karolinska University Hospital · SE
Area of research
Rheumatology · Surgery
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Cholangiocarcinoma and Gallbladder Cancer Studies, Monoclonal and Polyclonal Antibodies Research, and Immune Cell Function and Interaction.
h-index
27
citations
2,562
works
81
NIH funding
primary concept
Medicine
email

Recent publications

Transient tissue residency and lymphatic egress define human CD56bright NK cell homeostasis
Nature Immunology 2025cited by 5position: middledoi
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention
Advanced Science 2024cited by 19position: middledoi
Immunobiology of primary sclerosing cholangitis
Hepatology 2024cited by 15position: firstdoi
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Annals of the Rheumatic Diseases 2023cited by 45position: middledoi
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
Respiratory Research 2023cited by 37position: middledoi
Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis
Journal of Hepatology 2022cited by 63position: middledoi
Impact on follow‐up strategies in patients with primary sclerosing cholangitis
Liver International 2022cited by 43position: middledoi
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Proceedings of the National Academy of Sciences 2021cited by 136position: middledoi
Continuous human uterine NK cell differentiation in response to endometrial regeneration and pregnancy
Science Immunology 2021cited by 127position: middledoi
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
Proceedings of the National Academy of Sciences 2021cited by 90position: middledoi
A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells
Science Translational Medicine 2021cited by 86position: middledoi
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Science Translational Medicine 2021cited by 20position: middledoi
Natural killer cell immunotypes related to COVID-19 disease severity
Science Immunology 2020cited by 511position: middledoi
MAIT cell activation and dynamics associated with COVID-19 disease severity
Science Immunology 2020cited by 210position: middledoi
Presence of autoantibodies in “seronegative” rheumatoid arthritis associates with classical risk factors and high disease activity
Arthritis Research & Therapy 2020cited by 74position: middledoi
MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis
Hepatology 2020cited by 59position: middledoi
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
Frontiers in Immunology 2019cited by 70position: middledoi
NK cells are activated and primed for skin-homing during acute dengue virus infection in humans
Nature Communications 2019cited by 68position: middledoi
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants
Annals of the Rheumatic Diseases 2017cited by 57position: middledoi
Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases
Clinical Immunology 2015cited by 69position: middledoi
Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort
RMD Open 2015cited by 24position: middledoi
Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort
Annals of the Rheumatic Diseases 2013cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Niklas K. Björkström · Karolinska University Hospital8 papers (2015–2024) · 5 papers (2013–2023)Annika Bergquist · Karolinska University Hospital4 papers (2021–2024)Karl Skriner · Freie Universität Berlin3 papers (2017–2023) · 3 papers (2017–2023)Lars Alfredsson · University of Pennsylvania3 papers (2017–2023)Christine L. Zimmer · Philipps University of Marburg3 papers (2019–2021)Johan Rönnelid · Science for Life Laboratory3 papers (2017–2023)Monika Hansson · Karolinska University Hospital3 papers (2017–2023)Per Johan Jakobsson · Karolinska University Hospital3 papers (2017–2023)Rikard Holmdahl · Uppsala University3 papers (2017–2023) · 2 papers (2013–2015)P. Nicaise‐Roland · Université Claude Bernard Lyon 12 papers (2013–2015)Martin A. Ivarsson · Karolinska University Hospital2 papers (2019–2021)Benedikt Strunz · Karolinska University Hospital2 papers (2020–2021)Karin Lundberg · Karolinska University Hospital2 papers (2017–2020)Kristian Holm · Oslo University Hospital2 papers (2021–2021)Lars Klareskog · Karolinska University Hospital2 papers (2017–2023)Kimia T. Maleki · Karolinska Institutet2 papers (2015–2021) · 2 papers (2013–2015)